Antidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13224

Title:	Antidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models
Authors:	Mahesh, R.
Keywords:	Pharmacy Anxiety Behavioural tests Depression N-(pyridin-3-yl) quinoxalin-2-carboxamide Novel 5-HT3 antagonist Serotonin system
Issue Date:	2016
Publisher:	IJMR
Abstract:	Alteration in the serotonin leads to the psychological illness, such as depression, anxiety, schizophrenia, eating disorders, obsessive-compulsive disorder, panic disorders and migraines. The objective of the current study was to investigate the antidepressant and anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide (QCF-21), a novel 5-HT3 receptor antagonist in preclinical models of depression and anxiety.
URI:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345311/ http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13224
Appears in Collections:	Department of Pharmacy

Files in This Item:

There are no files associated with this item.